generic-drugs

It was agreed that in an overwhelming public health emergency, poor countries would be allowed to produce generic drugs.

"They still dominate here" with active pharmaceutical ingredients, "but finished generic drugs are their future, " he said.

The industry is witnessing increased competition from generic drugs as an unprecedented number of branded medicines lose patent protection.

serious adverse events from bioavailability studies, as well as bioequivalence studies in the case of generic drugs.

The sizeable profits they have made from generics also look as if they will peak, since 2006 is the biggest year for new generic drugs.

Where the scoring configuration is protected by patent, contact the Office of Generic Drugs for guidance.

To complicate matters further, legal definitions of counterfeit medicines are often so broad that they include generic drugs.

India has benefited in the last 50 years from its scientists delivering affordable generic drugs to the market.

You can check all the clinical studies for a variety of ailment and we tell you the best generic drugs that work.

There is also hope that two older generic drugs, amantadine and rimantadine, might be effective against bird flu.

Although provinces cap the amount they pay for generic drugs at a fixed fraction of the branded price, they have set the bar too high.

And that pharmaceutical companies should create high-quality generic drugs that won't break a family's budget.

He sees his firm becoming one of the world's top producers of generic drugs within five years.

Heart patients in a Beijing hospital. New generic drugs could treat such ailments more cheaply.

Compared with other generic drugs, lumbrokinase causes few ADR and has high safety as well as efficacy.

GENERIC drugs are the scourge of the pharmaceutical industry.

As the owner of Ranbaxy, Daiichi Sankyo now shares interests with other foreign makers of generic drugs.

Things get more complicated when anti-counterfeiting laws are so broad that they encompass generic drugs.

Given worldwide pressure to reduce health costs, there were hopes that producers of cheaper generic drugs would perform well.

Those sales will then collapse as copycat products are churned out by the producers of generic drugs.

First, the developed world. In 2010 rich countries will boost the fortunes of generic drugs in two ways.

A petition has been launched to oppose a court case prohibiting Indian companies' ability to make cheap, generic drugs.

Sub-Saharan African countries, and India itself, rely heavily on cheap Indian generic drugs.

Reuters reported (25 November) that Egypt will license five companies to produce five million doses of generic drugs in 2010.

Rather, the key is to pitch branded generic drugs.

earlier this week , i also announced action to bring lower cost generic drugs to market more quickly.

But sales of generic drugs are surging three times faster.

We are working very hard to get generic drugs to people as soon as the law will allow.

Objective To introduce WHO's biowaiver policy for oral generic drugs.

Abbott Laboratories (ABT) recently agreed to acquire the generic-drugs unit of India's Piramal Healthcare Ltd. for $3. 7 billion.

Who pays the most for branded and generic drugs?

Generic drugs are cheaper in part because they do an end - run around those trials.

From 1999 to 2008, the use of generic drugs saved America some $734 billion.

Low Cost Health Insurance - Knowing The. Low Cost Health Insurance: Deductibles, Co-Pay, Generic Drugs, Preventative Care

Opportunities and Challenges for Bioequivalent Generic Drugs in Brazil

This is despite two significant exceptions: in pharmaceuticals, where the challengers have tended to make low-margin generic drugs;

Analysis on the Problems Existing in the Application Dossier of Generic Drugs

The International Strategy of Generic Drugs

International Forum for Generic Drugs

Opportunities and Challenges for Generic Drugs in the UK

Inhalation Nasal Spray Generic Drugs